Director Kingshott buys 9,350 RXO shares at $10.75; stock down -64.5% from $30.88 high amid cluster buy by 2 other insiders
Director Adrian Kingshott purchased 9,350 shares at $10.75 on 2025-11-17, increasing his holdings from 81,787 to 91,137 shares (+11.4%), while the stock trades at $10.96—down -64.5% from its 52-week high of $30.88 and off -39.6% over the past 30 days. This purchase occurs as part of a cluster pattern, with 2 other insiders also buying within the past 14 days. The company generated $1.4B in revenue (latest quarter) with +15.9% annual growth but reported a $-14.0M net loss in that quarter and was unprofitable over its most recent full fiscal year. The coordinated buying by three insiders during a steep decline merits examination, though the company's current unprofitability and ongoing negative earnings warrant caution regarding what such purchases may signal about future performance.